Claritev (CTEV) BofA Securities Leveraged Finance Conference 2025 summary

Strategic direction and business transformation

• 2024 focused on building a foundation, 2025 marked a successful turnaround, and the current focus is on sustainable growth.

• Emphasis on core business strength and asset base, with five internal P&Ls and six new market segments activated.

• Prioritization of a few critical initiatives closely aligned with core markets.

• Stabilization achieved through financial discipline, resource allocation, and executive engagement with top clients.

• Introduction of segment leadership and accountability, with a focus on pipeline hygiene and credible forecasting.

Go-to-market strategy and new market segments

• Significant R&D investment split between supporting current products and new initiatives.

• Expansion into provider, government, employer, broker, and international markets, with new products like CompleteView and BenInsights.

• Advanced Code Editing product successfully deployed in the Middle East, reducing denial rates and creating economic value.

• Government segment opened with wins in federal agencies, including a large CDC subcontract.

• Employer solutions embedded in human capital management platforms, enabling faster sales cycles and broader reach.

International expansion and competitive positioning

• International strategy developed post-refinancing, leveraging U.S. coding standards in 32 countries.

• Addressable market includes three dozen countries with U.S.-style healthcare inefficiencies.

• Unique approach to denial management for providers, with little direct competition in target markets.

• Proof of value in international markets will drive further investment and expansion.